About the journal
- Alopecia Areata – Autoimmune Inflammatory Disease and a New Targeted Treatment Option
- SCOPE 2021 – State of Osteoporosis and Its Treatment in European Countries
- Bimekizumab in 3rd Line Biological Treatment After Risankizumab Failure – Case Study
- Changes in Intestinal Microflora Correlate with Disease Activity in Patients with Lupus Erythematosus